Pyridinium crosslinks of collagen as a marker of bone resorption rates in children and adolescents: Normal values and clinical application
- 31 December 1996
- Vol. 19 (6), 669-677
- https://doi.org/10.1016/s8756-3282(96)00284-0
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Carboxy-terminal propeptide of human type I collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of ageJournal of Bone and Mineral Research, 1995
- The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone diseaseJournal of Clinical Endocrinology & Metabolism, 1995
- Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: Results of a pilot studyJournal of Bone and Mineral Research, 1994
- Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptidesBone, 1994
- Urinary excretion of hydroxy-pyridinium cross-links of collagen reflects skeletal growth velocity in normal childrenExperimental and Clinical Endocrinology & Diabetes, 1994
- Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapyJournal of Clinical Endocrinology & Metabolism, 1992
- Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture.Annals Of The Rheumatic Diseases, 1992
- Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagenThe Journal of Pediatrics, 1989
- Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.Archives of Disease in Childhood, 1976
- RADIOGRAPHIC ATLAS OF SKELETAL DEVELOPMENT OF THE HAND AND WRISTThe American Journal of the Medical Sciences, 1959